CTRI/2022/09/045191尚未招募未知
Evaluation of intraocular pressure lowering effect of 0.4% Ripasudil eye drops in patients with primary open angle glaucoma and ocular hypertension
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with Central Corneal Thickness corrected intraocular pressure more than or equal to 22mmHg which includes primary open angle glaucoma and ocular hypertension
排除标准
- •Patients with history of ocular trauma
- •Patients with history of intraocular surgery
- •Secondary glaucomas like angle closure glaucoma, neovascular glaucoma, pseudo-exfoliative glaucoma, pigmentary glaucoma
- •Patients with pre-existing corneal diseases
- •Pre-existing dry eye
- •Patients with allergic conjunctivitis
- •Pregnant and lactating women
- •Patients who are not willing for follow up
研究者
相似试验
已完成
不适用
A study of the intraocular pressure lowering effect of topical application of ripasudil in clinical practiceGlaucomaJPRN-UMIN000025466Kobe University Graduate School of Medicine130
已完成
不适用
Evaluation of the Intraocular pressure lowering effect of Tafluprost and Latanoprost on normal tension GlaucomaGlaucomaJPRN-UMIN000002017Department of ophthalmology, Kyoto Prefectural University of Medicine30
已完成
不适用
Comparison of intraocular pressure lowering effects among four prostaglandin analogues: parallel administration to the bilateral eyes of normal subjects.glaucoma, ocular hypertensionJPRN-UMIN000003810Department of Ophthalmology, Houju Memorial Hospital25
尚未招募
不适用
Generic Latanoprost: An Equivalent Comparison Open-labelled StudyTCTR20180115001Bausch & Lomb Co., Ltd.70
已完成
3 期
A Study Assessing the Safety and Efficacy of DE-117 in Subjects With POAG or OH Who Are Non-/Low-responders to Latanoprost: FUJI StudyPrimary Open Angle Glaucoma or Ocular HypertensionNCT02822742Santen Pharmaceutical Co., Ltd.26